日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Consolidation ALK Tyrosine Kinase Inhibitors Versus Durvalumab or Observation After Chemoradiation in Unresectable Stage III ALK-Positive NSCLC

不可切除的III期ALK阳性非小细胞肺癌患者接受放化疗后,ALK酪氨酸激酶抑制剂巩固治疗与度伐利尤单抗或观察的比较

Nassar, Amin H; Jayakrishnan, Ritujith; Feng, Jamie; Shepherd, Frances; Adib, Elio; Cheung, Justin M; Lin, Jessica J; Liu, Yufei; Lin, Steven H; Parikh, Kaushal; Sridhar, Arthi; Shakya, Purnima; Dilling, Thomas J; Kaldas, David; Gray, Jhanelle E; Lobachov, Anastasiya; Bar, Jair; Luders, Heike; Grohe, Christian; Gupta, Shruti; Leal, Ticiana; Fitzgerald, Bailey; Crowley, Fionnuala; Fujiwara, Yu; Marron, Thomas U; Wilgucki, Molly; Reuss, Joshua; Chen, Luxi; Sankar, Kamya; Aredo, Jacqueline V; Neal, Joel W; Wakelee, Heather A; Thummalapalli, Rohit; Yu, Helena; Whitaker, Ryan; Velazquez, Ana; Ragavan, Meera; Cortellini, Alessio; Kwiatkowski, David J; Naqash, Abdul Rafeh; Goldberg, Sarah B; Kim, So Yeon

Transformer-based AI approach to unravel long-term, time-dependent prognostic complexity in patients with advanced NSCLC and PD-L1 ≥50%: insights from the pembrolizumab 5-year global registry

基于Transformer的AI方法揭示晚期非小细胞肺癌(NSCLC)且PD-L1表达≥50%患者的长期、时间依赖性预后复杂性:来自帕博利珠单抗5年全球注册研究的启示

Cortellini, Alessio; Santo, Valentina; Brunetti, Leonardo; Garbo, Edoardo; Pinato, David J; La Cava, Giulia; Naidoo, Jarushka; Katz, Artur; Loza, Monica; Neal, Joel W; Genova, Carlo; Gettinger, Scott; Kim, So Yeon; Jayakrishnan, Ritujith; El Zarif, Talal; Russano, Marco; Pecci, Federica; Di Federico, Alessandro; Alessi, Joao V; Montrone, Michele; Owen, Dwight H; Ramella, Sara; Signorelli, Diego; Fidler, Mary Jo; Li, Mingjia; Camerini, Andrea; Halmos, Balazs; Vincenzi, Bruno; Metro, Giulio; Passiglia, Francesco; Yendamuri, Sai; Guida, Annalisa; Ghidini, Michele; D'Alessio, Antonio; Banna, Giuseppe L; Fulgenzi, Claudia A M; Grisanti, Salvatore; Grossi, Francesco; D'Incecco, Armida; Josephides, Eleni; Van Hemelrijck, Mieke; Russo, Alessandro; Gelibter, Alain; Spinelli, Gianpaolo; Verrico, Monica; Tomasik, Bartłomiej; Giusti, Raffaele; Balachandran, Kirsty; Bria, Emilio; Sebastian, Martin; Rost, Maximilian; Forster, Martin; Mukherjee, Uma; Landi, Lorenza; Mazzoni, Francesca; Aujayeb, Avinash; Dupont, Manuel; Curioni-Fontecedro, Alessandra; Chiari, Rita; Sforza, Vincenzo; Tiseo, Marcello; Friedlaender, Alex; Addeo, Alfredo; Zoratto, Federica; De Tursi, Michele; Cantini, Luca; Roca, Elisa; Mountzios, Giannis; Rocco, Danilo; Della Gravara, Luigi; Kalvapudi, Sukumar; Inno, Alessandro; Bironzo, Paolo; Di Marco Barros, Rafael; O'Reilly, David; Fitzpatrick, Orla; Karapanagiotou, Eleni; Monnet, Isabelle; Baena, Javier; Macerelli, Marianna; Piedra, Aida; Agustoni, Francesco; Cortinovis, Diego Luigi; Tonini, Giuseppe; Minuti, Gabriele; Bennati, Chiara; Mezquita, Laura; Gorría, Teresa; Servetto, Alberto; Beninato, Teresa; Lo Russo, Giuseppe; Prelaj, Arsela; De Giglio, Andrea; Rogado, Jacobo; Moliner, Laura; Nadal, Ernest; Biello, Federica; Nana, Frank Aboubakar; Dingemans, Anne-Marie; Aerts, Joachim G J V; Ferrara, Roberto; Abu Hejleh, Taher; Takada, Kazuki; Naqash, Abdul Rafeh; Garassino, Marina Chiara; Peters, Solange; Wakelee, Heather A; Nassar, Amin H; Ricciuti, Biagio; Soda, Paolo; Caruso, Camillo Maria; Guarrasi, Valerio

Determinants of 5-year survival in patients with advanced NSCLC with PD-L1≥50% treated with first-line pembrolizumab outside of clinical trials: results from the Pembro-real 5Y global registry

在临床试验之外,接受一线帕博利珠单抗治疗的PD-L1≥50%晚期非小细胞肺癌患者的5年生存率决定因素:来自Pembro-real 5Y全球注册研究的结果

Cortellini, Alessio; Brunetti, Leonardo; Di Fazio, Giuseppina Rita; Garbo, Edoardo; Pinato, David J; Naidoo, Jarushka; Katz, Artur; Loza, Monica; Neal, Joel W; Genova, Carlo; Gettinger, Scott; Kim, So Yeon; Jayakrishnan, Ritujith; El Zarif, Talal; Russano, Marco; Pecci, Federica; Di Federico, Alessandro; Awad, Mark; Alessi, Joao V; Montrone, Michele; Owen, Dwight Hall; Signorelli, Diego; Fidler, Mary Jo; Li, Mingjia; Camerini, Andrea; De Giglio, Andrea; Young, Lauren; Vincenzi, Bruno; Metro, Giulio; Passiglia, Francesco; Yendamuri, Sai; Guida, Annalisa; Ghidini, Michele; Awosika, Nichola O; Napolitano, Andrea; Fulgenzi, Claudia A M; Grisanti, Salvatore; Grossi, Francesco; D'Incecco, Armida; Josephides, Eleni; Van Hemelrijck, Mieke; Russo, Alessandro; Gelibter, Alain; Spinelli, Gianpaolo; Verrico, Monica; Tomasik, Bartłomiej; Giusti, Raffaele; Newsom-Davis, Thomas; Bria, Emilio; Sebastian, Martin; Rost, Maximilian; Forster, Martin; Mukherjee, Uma; Landi, Lorenza; Mazzoni, Francesca; Aujayeb, Avinash; Dupont, Manuel; Curioni-Fontecedro, Alessandra; Chiari, Rita; Pantano, Francesco; Morabito, Alessandro; Leonetti, Alessandro; Friedlaender, Alex; Addeo, Alfredo; Zoratto, Federica; De Tursi, Michele; Cantini, Luca; Roca, Elisa; Mountzios, Giannis; Della Gravara, Luigi; Kalvapudi, Sukumar; Inno, Alessandro; Bironzo, Paolo; Di Marco Barros, Rafael; O'Reilly, David; Bell, Jack; Karapanagiotou, Eleni; Monnet, Isabelle; Baena, Javier; Macerelli, Marianna; Majem, Margarita; Agustoni, Francesco; Cortinovis, Diego Luigi; Tonini, Giuseppe; Minuti, Gabriele; Bennati, Chiara; Mezquita, Laura; Gorría, Teresa; Servetto, Alberto; Beninato, Teresa; Lo Russo, Giuseppe; Rogado, Jacobo; Moliner, Laura; Biello, Federica; Aboubakar Nana, Frank; Dingemans, Anne-Marie; Aerts, Joachim G J V; Ferrara, Roberto; Torri, Valter; Hejleh, Taher Abu; Takada, Kazuki; Naqash, Abdul Rafeh; Garassino, Marina; Peters, Solange; Wakelee, Heather; Nassar, Amin H; Ricciuti, Biagio

Clonal Hematopoiesis Is Associated With Cardiomyopathy During Solid Tumor Therapy

克隆性造血与实体瘤治疗期间的心肌病相关

Leveille, Etienne; Jaber Cheheyeb, Rachel; Matute-Martinez, Carlos; Chen, Nathan W; Jayakrishnan, Ritujith; Christofides, Anthos; Lin, Derrick; Im, Yunju; Biancon, Giulia; VanOudenhove, Jennifer; Halene, Stephanie; Kwan, Jennifer M

Topography of mutational signatures in non-small cell lung cancer: emerging concepts, clinical applications, and limitations

非小细胞肺癌突变特征的拓扑结构:新兴概念、临床应用和局限性

Jayakrishnan, Ritujith; Kwiatkowski, David J; Rose, Michal G; Nassar, Amin H

Clonal hematopoiesis of indeterminate potential is associated with increased risk of immune checkpoint inhibitor myocarditis in a prospective study of a cardio-oncology cohort

一项针对心脏肿瘤患者队列的前瞻性研究表明,具有不确定潜能的克隆性造血与免疫检查点抑制剂心肌炎风险增加相关。

Jaber Chehayeb, Rachel; Singh, Jaiveer; Matute-Martinez, Carlos; Chen, Nathan W; Guajardo, Ana Ferrigno; Lin, Derrick; Jayakrishnan, Ritujith; Christofides, Anthos; Leveille, Etienne; Im, Yunju; Biancon, Giulia; VanOudenhove, Jennifer; Ibrahim, Eiman; Ardasheva, Anastasias; Jha, Alokkumar; Hwa, John; Halene, Stephanie; Kwan, Jennifer M

Doxepin for Radiation Therapy-Induced Mucositis Pain in the Treatment of Oral Cancers

多塞平用于治疗口腔癌放射治疗引起的黏膜炎疼痛

Jayakrishnan, Ritujith; Chang, Kenneth; Ugurluer, Gamze; Miller, Robert C; Sio, Terence T